Pri-Med Podcasts

Preventing Overdose Deaths with Naloxone: Harm Reduction vs Encouraging Use - Frankly Speaking EP 296

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-296
 
Overview: The number of drug overdoses in the United States continues to rise in tandem with the growing opioid epidemic. In 2020, nearly 92,000 people died from drug overdoses in the United States, which was an approximate 31% increase in just one year. This episode will highlight perceived barriers to harm reduction and show primary care providers how they can play a key role in overdose prevention. 
 
Episode resource links:
https://www.cdc.gov/opioids/overdoseprevention/reverse-od.html
https://www.cdc.gov/drugoverdose/deaths/index.html#:~:text=Drug%20Overdose%20Deaths%20Remain%20High&text=Opioids%E2%80%94mainly%20synthetic%20opioids%20(other,of%20all%20drug%20overdose%20deaths).
Bonner, L. (2022). As the opioid epidemic takes a turn for the worse, do we need more potent forms of naloxone?. Pharmacy Today, 28(3), 26.
Messmer, S., & Jarrett, J. (2022). When Naloxone Isn’t Enough. New England Journal of Medicine.
Tse, W. C., Djordjevic, F., Borja, V., Picco, L., Lam, T., Olsen, A., ... & Nielsen, S. (2022). Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’associated with naloxone supply. International Journal of Drug Policy, 100, 103513.
 
Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Richard Onorato

Suspecting COPD: What If the Spirometry Result Is Normal? - Frankly Speaking EP 295

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-295
 
Overview: Chronic obstructive pulmonary disease (COPD) is typically diagnosed based on spirometry findings, but what if that finding isn’t what you expect? Spirometry measurements are compared to standard values for age, sex, and race. The use of race-based equations has been questioned in several clinical situations, and researchers are now raising similar concerns about the use of race-based equations in spirometry, which may lead to health inequities. Join us for an important discussion on how to overcome these potential disparities in diagnosing COPD.
 
Episode resource links:
Liu GY, Khan SS, Colangelo LA, et al. Comparing Racial Differences in Emphysema Prevalence Among Adults With Normal Spirometry: A Secondary Data Analysis of the CARDIA Lung Study [published online ahead of print, 2022 Jul 19]. Ann Intern Med. 2022;10.7326/M22-0205.
 
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato

Avoiding Treatment Delays: Case Conversations in Type 2 Diabetes

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/case-conversation-t2dm-part-2
Overview: In the context of a clinical case, faculty will emphasize the importance of developing a guideline-directed diabetes care management plan that places GLP-1 RA therapy before insulin.

Addressing Clinicians’ Challenges and Misinformation Around New and Emerging Treatments for Alzheimer Disease

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/alzheimer-disease-addressing-challenges-pt2
Overview: Alzheimer disease (AD) treatment is evolving. With this rapid expansion in potential therapies, there remain challenges and misconceptions. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions about new and emerging disease-modifying therapies and explores ways in which these treatments may be considered in the future for patients. 
The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: Early Recognition and Emerging Therapy.

Addressing Clinicians’ Challenges and Misinformation Around Diagnosis of Alzheimer Disease

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/alzheimer-disease-addressing-challenges-pt1
Overview: Alzheimer disease (AD) is a growing concern as the population ages. Primary care clinicians are often the first to screen for and identify signs of cognitive impairment which may be due to AD. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions and provides helpful tips for assessing cognitive impairment in primary care and provides insight into the current and emerging role of neuroimaging and biomarkers in the diagnosis of AD.
The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: Early Recognition and Emerging Therapy.

Proving Cassandra Wrong: The Case For Migraine Prevention

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/case-for-migraine-prevention
Overview: This podcast will focus on the case of a patient with migraine attacks that have been increasing in frequency and the disability they cause. Faculty will discuss when to initiate preventive migraine treatment and consider medication options for this patient that will take into account her comorbid conditions and potential issues with adherence.

Your Questions About Migraine Work-Up And Prevention Answered

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/your-questions-about-migraine-pt2
Overview: In this podcast, Drs. Dawn Buse and Michael Ready will address questions about migraine diagnosis and treatment posed by Pri-Med learners during recent programs. Topics will include red flags requiring evaluation for serious secondary causes of headache, tips on encouraging patients to use headache diaries, the role of supplements in migraine prevention, and more!

The Best Evidence for Treating Fibromyalgia - Frankly Speaking EP 294

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-294
 
Overview: Fibromyalgia is a common and difficult to diagnose disease, with highly subjective symptoms. Another challenge is that treatment is dependent on a patient’s implementation lifestyle changes. This brief podcast walks you through the diagnosis of fibromyalgia and offers best evidence on effective treatments.
 
Episode resource links:
Mediations:  JAMA Netw Open. 2022;5(5):e2212939
Acupuncture:  J Pain Res. 2022; 15: 315–329
 
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato

Wait Before Writing That Antibiotic Prescription! Is it appropriate? - Frankly Speaking EP 293

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-293
 
Overview: Evidence informs us that almost one-third of antibiotic prescriptions written for children in the United States are inappropriate, meaning they are not in line with evidence-based guidelines. Antibiotics are tremendous tools and beneficial when used appropriately; however, as with all pharmacological therapy, there are risks of adverse effects and healthcare cost. When prescribed inappropriately, they unnecessarily put children at risk and cause financial burden on individuals and the system. Please join the podcast team as we discuss recent evidence on these risks and burden and consider how this evidence can help improve practice. 
 
Episode resource links:
Butler AM, Brown DS, Durkin MJ, et al. Association of Inappropriate Outpatient Pediatric Antibiotic Prescriptions With Adverse Drug Events and Health Care Expenditures. JAMA Netw Open.2022;5(5):e2214153. doi:10.1001/jamanetworkopen.2022.14153
 
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato

To Add Insulin or Not to Add Insulin: Case Conversations in Type 2 Diabetes

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/case-conversation-t2dm
Overview: In the context of a clinical case, faculty will emphasize the importance of developing a guideline-directed diabetes care management plan that places GLP-1 RA therapy before insulin.